InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Xu Yuan, Director. Insider active across 3 companies, notably Akero Therapeutics, Inc.. Cumulatively, 11 disclosures have been recorded. The latest transaction was disclosed on 5 May 2026 — Purchase. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations11 total
9,398 shares
Common Stock
SEC:0001193125-25-312133·
9,398 shares
Common Stock
SEC:0001193125-25-312133:0·
08,650 shares0
Common Stock
SEC:0001209191-22-036355:0·
04,744 shares0
Common Stock
SEC:0001209191-21-049914·
04,744 shares0
Common Stock
SEC:0001209191-21-049914:0·
11 of 11 declarations
About Xu Yuan
Xu Yuan serves as a Director at Akero Therapeutics, Inc., FATE THERAPEUTICS INC, and IGG Inc. With significant experience in the biopharmaceutical sector, he contributes to the strategic direction and governance of these companies. His role involves overseeing operations and evaluating company performance while ensuring shareholder interests are upheld. Xu Yuan is recognized for his expertise in product development and risk management, allowing him to add value to each organization he is involved with.
